Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M D Magri

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
European Journal of Cancer (Oxford, England : 1990)|November 1, 2000
Determination of tamoxifen and its metabolites in the endometrial tissue of long-term treated womenG Giorda, L Franceschi, D Crivellari, et al.
European Journal of Cancer (Oxford, England : 1990)|September 1, 1996
Vinorelbine treatment of advanced non-small cell lung cancer with special emphasis on elderly patientsA Veronesi, D Crivellari, M D Magri, et al.
Tumori|March 18, 1999
Does the information level of cancer patients correlate with quality of life? A prospective studyM A Annunziata, S Foladore, M D Magri, et al.
Critical Reviews in Oncology/Hematology|June 7, 2003
Treatment of older breast cancer patients with high recurrence riskD Crivellari, S Spazzapan, D Lombardi, et al.
Tumori|August 31, 1983
Non-platinum-containing combination chemotherapy for stage III-IV head and neck squamous carcinomaA Veronesi, M D Magri, U Tirelli, et al.
Medical and Pediatric Oncology|January 1, 1983
Chlorozotocin treatment of advanced gastrointestinal cancerA Veronesi, M D Magri, U Tirelli, et al.
Tumori|July 25, 1998
Tamoxifen as adjuvant after surgery for breast cancer and tamoxifen or placebo as chemoprevention in healthy women: different compliance with treatmentA Veronesi, M A Pizzichetta, M A Ferlante, et al.
Tumori|April 25, 2000
Continuous infusion fluorouracil in the management of advanced breast cancer: a phase II studyD Crivellari, M D Magri, A Buonadonna, et al.
Tumori|February 1, 1980
[Oncology outpatient clinic in a general hospital]E Galligioni, A Veronesi, M G Trovò, et al.
Tumori|October 24, 2001
Fourteen-day infusion of ifosfamide in the management of advanced breast cancer refractory to protracted continuous infusion of 5-fluorouracilV D Lauro, S Spazzapan, D Lombardi, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
European Journal of Cancer (Oxford, England : 1990)|November 1, 2000
Determination of tamoxifen and its metabolites in the endometrial tissue of long-term treated womenG Giorda, L Franceschi, D Crivellari, et al.
European Journal of Cancer (Oxford, England : 1990)|September 1, 1996
Vinorelbine treatment of advanced non-small cell lung cancer with special emphasis on elderly patientsA Veronesi, D Crivellari, M D Magri, et al.
Tumori|March 18, 1999
Does the information level of cancer patients correlate with quality of life? A prospective studyM A Annunziata, S Foladore, M D Magri, et al.
Critical Reviews in Oncology/Hematology|June 7, 2003
Treatment of older breast cancer patients with high recurrence riskD Crivellari, S Spazzapan, D Lombardi, et al.
Tumori|August 31, 1983
Non-platinum-containing combination chemotherapy for stage III-IV head and neck squamous carcinomaA Veronesi, M D Magri, U Tirelli, et al.
Medical and Pediatric Oncology|January 1, 1983
Chlorozotocin treatment of advanced gastrointestinal cancerA Veronesi, M D Magri, U Tirelli, et al.
Tumori|July 25, 1998
Tamoxifen as adjuvant after surgery for breast cancer and tamoxifen or placebo as chemoprevention in healthy women: different compliance with treatmentA Veronesi, M A Pizzichetta, M A Ferlante, et al.
Tumori|April 25, 2000
Continuous infusion fluorouracil in the management of advanced breast cancer: a phase II studyD Crivellari, M D Magri, A Buonadonna, et al.
Tumori|February 1, 1980
[Oncology outpatient clinic in a general hospital]E Galligioni, A Veronesi, M G Trovò, et al.
Tumori|October 24, 2001
Fourteen-day infusion of ifosfamide in the management of advanced breast cancer refractory to protracted continuous infusion of 5-fluorouracilV D Lauro, S Spazzapan, D Lombardi, et al.
Pageof 3